These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31061546)

  • 1. THE CHALLENGE OF ACHIEVING ADEQUATE ORAL IMMUNOSUPPRESSION IN A RENAL TRANSPLANT RECIPIENT WHO DEVELOPS SHORT BOWEL SYNDROME (SBS).
    McCloskey OM; Woodman A; Mitchell A; Smyth J
    Ulster Med J; 2018 Oct; 87(3):200-201. PubMed ID: 31061546
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of oral tacrolimus in a case of short bowel syndrome.
    Patel N; Smith S; Handa A; Darby C
    Transpl Int; 2004 Jan; 17(1):44-5. PubMed ID: 12955349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil improves Sandimmune immunosuppression, reducing acute rejection episodes.
    Citterio F; Serino F; Pozzetto U; Fioravanti P; Caizzi P; Castagneto M
    Transplant Proc; 1996 Aug; 28(4):2174-6. PubMed ID: 8769192
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine: the principal immunosuppressant for renal transplantation.
    Keown PA; Primmett DR
    Transplant Proc; 1998 Aug; 30(5):1712-5. PubMed ID: 9723252
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M
    Transplant Proc; 1999; 31(1-2):1131-2. PubMed ID: 10083505
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination of cyclosporin and ketoconazole in immunosuppression schemes in patients with transplanted kidney].
    Treĭvish VS; Shoĭkhet IN; Ankova EV
    Klin Med (Mosk); 1998; 76(1):40-2. PubMed ID: 9532915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of living related renal transplantation in a patient with short bowel syndrome.
    Takeda I; Kawagishi N; Sekiguchi S; Akamatsu Y; Sato K; Miyagi S; Fujimori K; Satomi S
    Tohoku J Exp Med; 2010 Jun; 221(2):113-8. PubMed ID: 20467233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Rinsho; 2005 May; 63 Suppl 5():684-91. PubMed ID: 15954430
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine.
    Shihab FS; Cibrik D; Chan L; Kim YS; Carmellini M; Walker R; Zibari G; Pattison J; Cornu-Artis C; Wang Z; Tedesco-Silva H
    Clin Transplant; 2013; 27(2):217-26. PubMed ID: 23230975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-free maintenance immunosuppression and ABO-incompatible transplantation.
    Gloor J; Matas AJ
    Transplantation; 2010 Mar; 89(6):648-9. PubMed ID: 20010327
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoral vs Sandimmun: interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients. The U. K. Neoral Study Group.
    Lodge JP; Pollard SG
    Transplant Proc; 1997; 29(1-2):272-3. PubMed ID: 9122991
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients.
    Yeung S; Tsang WK; Tong KL; Wong SH; Lee W; Tang HL; Chan HW; Chan AY
    Transplant Proc; 2004 Sep; 36(7):2084-6. PubMed ID: 15518754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
    Løkkegaard H; Asmundsson P; Clausen P; Dieperink H; Hansen JM; Heaf J; Jensen SB; Kornerup HJ; Madsen S; Pedersen EB; Poulsen JV; Rasmussen K
    Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
    [No Abstract]   [Full Text] [Related]  

  • 17. Ursodeoxycholic acid enhances the absorption of cyclosporine in a heart transplant patient with short bowel syndrome.
    Gutzler F; Zimmermann R; Ring GH; Sauer P; Stiehl A
    Transplant Proc; 1992 Dec; 24(6):2620-1. PubMed ID: 1465887
    [No Abstract]   [Full Text] [Related]  

  • 18. Effective and Safe Reduction of Conventional Immunosuppressants Using Everolimus in Maintenance Kidney Transplant Recipients.
    Nanmoku K; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Yagisawa T
    Transplant Proc; 2017 Oct; 49(8):1724-1728. PubMed ID: 28923615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Converting immunosuppression from an oral suspension to a granule formulation of tacrolimus in pediatric renal transplant recipients.
    Malakasioti G; Booth C; Marks SD
    Pediatr Transplant; 2018 Aug; 22(5):e13214. PubMed ID: 29767471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group.
    Nashan B; Light S; Hardie IR; Lin A; Johnson JR
    Transplantation; 1999 Jan; 67(1):110-5. PubMed ID: 9921806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.